Big fundraising push for Columbus robotics company with Cleveland ties
Path Robotics has raised funding for its robotic welding systems, seen here in a rendering.
A Columbus-based artificial intelligence robotics company with connections to Case Western Reserve University has raised $56 million in Series B funding, a news release stated.
Path Robotics, which has designed an autonomous robotic welding system, has received a total of $71 million in investments. The company was started by brothers Andy and Alex Lonsberry, who studied at Case Western Reserve, along with their father, Ken Lonsberry, and with Matt Klein. Current industrial robotics have very little ability to understand their environment and the task at hand. Most robots merely repeat what they are told and have no ability to improve themselves. Our goal is to change this. The future of manufacturing hinges on highly capable robotics, CEO Andrew Lonsberry said in the release.
Path Robotics Raises $56M in Funding
Path Robotics, a Columbus, OH-based AI Robotics company designing an autonomous robotic welding system, raised $56m in Series B funding.
The round, which brought total funding raised to date to $71m, was led by Addition with participation from returning investors Drive Capital, Basis Set, and Lemnos Lab.
The company will use the funds to continue to expand its operations and development efforts.
Co-founded by brothers Andy and Alex Lonsberry, Matt Klein and their father, Ken Lonsberry, Path Robotics is developing artificial intelligence, machine learning, and computer vision systems to make industrial robots intelligent.
Through proprietary scanning and computer vision technology, the system can see and understand nearly any part it’s given with the ability to self-adjust for each unique part. It analyzes where a weld is needed and generates all the planning to execute a clean weld nearly instantly. The system was designed to op
Path Robotics Raises $56M to Build the Future of Manufacturing
The Series B financing is led by Addition
News provided by
Share this article
Share this article
COLUMBUS, Ohio, May 3, 2021 /PRNewswire/ Path Robotics, the Columbus-based AI Robotics company responsible for designing the world s first truly autonomous robotic welding system, today announced it received $56 million dollars in Series B funding, bringing the total invested in the company to $71 million. Addition led the round and was joined by returning investors Drive Capital, Basis Set, and Lemnos Lab. Path Robotics is solving a complex and critical problem in our country by bridging the gap between the supply of skilled welders and demand, said Lee Fixel of Addition. We look forward to supporting the company as it works to lead American manufacturing into the future.
Minnesota Senate GOP passes voter ID requirement Stephen Montemayor, Star Tribune
The Minnesota Senate on Monday passed a requirement that voters present photo identification at the polls, a longtime GOP priority with little to no chance of becoming law this year under the state s divided government.
Republican allegations of massive election fraud and Democratic accusations of a nationwide GOP campaign to restrict voting rights were on full display in the hourslong debate before a party-line vote. Millions of Americans are now lacking trust in our system, said state Sen. Scott Newman, a Hutchinson Republican who sponsored the legislation. This is one of the fastest and easiest ways we can restore their faith and protect the rights of all legal voters.
DAVID WAHLBERG
Wisconsin health officials have repeatedly declined to say how many residents have acquired COVID-19 after being fully vaccinated, even though theyâre tracking such âbreakthroughâ infections and federal officials have reported more than 7,000 cases nationally.
A new clinical study shows the Johnson and Johnson vaccine is about 66 percent effective against moderate to severe COVID-19.That also includes variants. It s the same number the company released earlier this year.Right now the Johnson and Johnson COVID-19 vaccine is on pause in the U.S. because of concerns over a possible link to rare cases of blood clots.Â
The U.S. total of 7,157 cases is among more than 87 million people who have received both doses of the Moderna or Pfizer injections or the single-dose Johnson & Johnson shot, the Centers for Disease Control and Prevention said last week. Thatâs about 0.008%.